Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Amgen opens Hyderabad Genome Valley center
Business R&D expansion

Amgen opens Hyderabad Genome Valley center

Analysis based on 17 articles · First reported Aug 11, 2026 · Last updated Aug 11, 2026

Sentiment
30
Attention
2
Articles
17
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement reinforces Amgen's commitment to expanding its global R&D footprint, potentially enhancing its drug discovery capabilities and long-term growth prospects. It also strengthens Hyderabad's position as a life sciences hub, which could attract further investment and talent to the region.

Biotechnology Pharmaceuticals
Event Summary

Amgen announced plans to establish a new Science and Innovation Centre at India — Genome Valley in Hyderabad, India, as part of its global R&D network. The facility, expected to be operational in 2027, will focus on discovery chemistry, drug metabolism and pharmacokinetics, precision medicine, and data science. It will complement Amgen's existing global capability centre in Hyderabad and its seven research laboratories worldwide. The company signed an MoU with the India — Telangana government, and the centre is expected to create around 200 highly skilled jobs. Amgen executives Jay Bradner, Som Chattopadhyay, and Naveen Gullapalli highlighted the integration of experimental science with data and technology, and the importance of India in Amgen's R&D network. India — Telangana Minister D. Sridhar Babu welcomed the investment as a boost to Hyderabad's life sciences ecosystem.

Key Actions
100 Amgen announced plans to open
80 Amgen signed MoU India — Telangana
Entities Involved
stock
Amgen
Amgen is the primary actor, announcing a new R&D center that expands its global research network and integrates science with technology, potentially accelerating drug development.
Importance 100.0 Sentiment 40.0
loc
India — Genome Valley
India — Genome Valley is the specific location of the new center, reinforcing its status as a leading life sciences cluster and benefiting from increased activity and investment.
Importance 70.0 Sentiment 50.0
per
Jay Bradner
As EVP of R&D, AI and Data, Jay Bradner is a key spokesperson, emphasizing the strategic value of the new center in integrating experimental science with data and technology.
Importance 60.0 Sentiment 30.0
loc
India — Telangana
India — Telangana is the host state, benefiting from Amgen's investment through job creation and enhanced reputation as a life sciences hub, potentially attracting further investments.
Importance 60.0 Sentiment 40.0
per
D. Sridhar Babu
As India — Telangana's Minister, D. Sridhar Babu welcomed the investment, reflecting the state's ambition to become a global life sciences hub and potentially boosting local economic development.
Importance 50.0 Sentiment 30.0
cnt
India
India becomes an important part of Amgen's global R&D network, strengthening its position in the global pharmaceutical and biotechnology industry.
Importance 50.0 Sentiment 30.0
per
Som Chattopadhyay
As SVP of Global Business Solutions, Som Chattopadhyay highlighted India's importance in Amgen's R&D network, supporting the company's expansion in the region.
Importance 40.0 Sentiment 20.0
per
Naveen Gullapalli
As Managing Director of Amgen India, Naveen Gullapalli emphasized Hyderabad's life sciences ecosystem and the center's role in integrating biotechnology and digital innovation.
Importance 40.0 Sentiment 20.0
Relationships
D. Sridhar Babu related ↔ India
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.